Hepatitis SA
Genotype Testing Genotyping is routinely performed prior to therapy. Genotype testing is covered by Medicare if you are considering treatment.
Genotype Distribution Globally, genotype 1 is most common, accounting for 46% of all infections, followed by genotypes 3 (22%), and genotypes 2 and 4 (13% each). There are significant variations across regions, with genotype 1 dominating in Australasia, Europe, Latin America and North America (53-71% of all cases) and genotype 3 accounting for 40% of all infections in Asia. Genotype 4 is most common (71%) in North Africa and the Middle East, but when figures from Egypt are excluded, it accounts for only 34% of infections, and genotype 1 accounts for 46% of infections. In Australia, the predominant genotypes are genotype 1 (54%) and genotype 3 (37%) with genotype 2 accounting for around 5%.
Helpline Hepatitis SA Helpline Do you have questions about hepatitis B or C? Get free info and support:
Do you have questions 1800 HEP ABC about hepatitis B or C?
orfree 1800 437 222 Get info and support: 9am–5pm, Mon-Fri
1800 HEP ABC or 1800 437 222 9am–5pm, Mon-Fri
www.hepatitissa.asn.au We provide • confidential and nonjudgemental support
www.hepatitissa.asn.au • up-to-date information • printed resources • referrals
Hepatitis SA
Ph 1800 437 222 or (08) 8362 8443 Fax (08) 8362 8559 3 Hackney Rd Hackney SA 5069 PO Box 782 Kent Town SA 5071 www.hepsa.asn.au
or come and speak to one of our team in person.
Call us 1800 437 222 9am–5pm, Mon–Fri Last update: July 2016 SA Health has contributed funds towards this Program.
Hepatitis C Genotypes